AIDS Vaccine This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest news and research items in this category.

15 thoughts on eliminating neglected tropical diseases
We summarise the points made by a live chat panel on how the global health community can work towards eliminating NTDsDr Paul Emerson, trachoma control programme director, The Carter Centre, Atlanta, USANTDs aren't as remote or obscure as many think: Trachoma and worms used to be endemic to the US and Europe, but were eliminated through improvements in hygiene, sanitation and access to medical care. NTDs still affect billions of people in the world, so the global NTD conversation needs to focus on how and why NTDs are keeping the bottom billion at the bottom.Build local support by involving community leaders: Involving tru...
Source: Guardian Unlimited Science - May 20, 2013 Category: Science Authors: Anna Scott Tags: Global health Guardian Professional Infectious diseases Pharmaceuticals industry Malaria and infectious diseases Vaccines and immunisation Health policy Editorial Global development professionals network Source Type: news

Comprehension of a simplified assent form in a vaccine trial for adolescents
Conclusions Youth enrolled in a Hepatitis B vaccine trial demonstrated variable comprehension of the study design and various methodological concepts, such as treatment group masking. (Source: Journal of Medical Ethics)
Source: Journal of Medical Ethics - May 19, 2013 Category: Medical Ethics Authors: Lee, S., Kapogiannis, B. G., Flynn, P. M., Rudy, B. J., Bethel, J., Ahmad, S., Tucker, D., Abdalian, S. E., Hoffman, D., Wilson, C. M., Cunningham, C. K., Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Tags: HIV/AIDS, Child health, Sexual health Brief report Source Type: research

The violence has ended but the emergency continues
Serge St-Louis recently returned from nine months working with Médecins Sans Frontières (MSF) in Central African Republic (CAR). He was in the field in late 2012, when Seleka, a new coalition of Central African rebel groups, took control of several towns before finally entering Bangui, the capital, in late March. He updates us on the post-conflict situation, including the issues and outlook for the country, its health care system and MSF. At the height of the crisis, confrontations, shootings and abuses occurred daily. Today, tension and violence have subsided and we are now in a particularly delicate phase – a sort o...
Source: MSF News - May 17, 2013 Category: Global & Universal Tags: Central African Republic NEWS Frontpage Source Type: news

New Tool Can Identify Powerful HIV Antibodies, Could Speed HIV Vaccine Research
A team of NIH scientists has developed a new tool to identify broadly neutralizing antibodies (bNAbs) capable of preventing infection by the majority of HIV strains found around the globe, an advance that could help speed HIV vaccine research. Scientists have long studied HIV-infected individuals whose blood shows powerful neutralization activity because understanding how HIV bNAbs develop and attack the virus can yield clues for HIV vaccine design... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 13, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

Nigeria: Africa, China Rub Minds On Aids, Malaria, Others
[Vanguard]Chinese and African leaders have met in Gaborone, Botswana, to discuss ways of jointly tackling critical issues such as AIDS, malaria,schistosomiasis, reproductive health, access to life-saving vaccines and non-communicable diseases among others, as the 4th International Roundtable on China-Africa Health Cooperation held to explore new partnerships to address pressing health challenges facing Africa and to strengthen an innovative health collaborative partnership. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - May 13, 2013 Category: Infectious Diseases Source Type: news

[News & Analysis] Aids Research: More Woes for Struggling HIV Vaccine Field
Devastating results from two trials have sent researchers scrambling—again.Author: Jon Cohen (Source: Science: Current Issue)
Source: Science: Current Issue - May 12, 2013 Category: Science Authors: Jon Cohen Source Type: research

Double-Dose Hepatitis B Revaccination in Nonresponsive HIV-Infected Adolescents
There is no consensus regarding a best dosing regimen of hepatitis B virus vaccine (HBVV) for non-responsive HIV-infected individuals. Double-dose of hepatitis B vaccine (DDHBVV) could enhance immunogenicity to HBVV in non-responsive HIV-infected adults. We assessed the immunogenicity of DDHBVV in HIV-infected adolescents who failed to respond to standard HBVV revaccination. HIV-infected adolescents with current CD4 ≥ 200 cells/mm3 and no protective antibody concentration of hepatitis B surface antibodies (antiHBs) after HBVV revaccination received DDHBVV, at months 0, 1, 2. The HBVV doses were 20 microgram per dose for...
Source: Journal of the International Association of Physicians in AIDS Care (JIAPAC) - May 10, 2013 Category: Infectious Diseases Authors: Bunupuradah, T., Ananworanich, J., Puthanakit, T. Tags: Short Communications Source Type: research

In HIV Vaccine Trial In Thailand, Competing Antibodies May Have Limited The Protection Achieved
Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people. In a study appearing in the journal Proceedings of the National Academy of Sciences, an international team of researchers led by the Duke Human Vaccine Institute describe a previously unknown interaction between antibodies that worked to block the vaccine's protective powers... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 8, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

Updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Released
The National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA) announce the release of the updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Selected key updates to the guidelines include the following: New information on the diagnosis and management of immune reconstitution inflammatory syndrome (IRIS), particularly as it relates to tuberculosis and cryptococcosis. New guidance for managing IRIS related to each opport...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - May 7, 2013 Category: Infectious Diseases Source Type: news

Another HIV Vaccine Failed: Where Do We Go From Here?Another HIV Vaccine Failed: Where Do We Go From Here?
Dr. Paul Sax considers the effects of halting the HVTN 505 study on the future of HIV vaccine research. Medscape HIV/AIDS (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2013 Category: Consumer Health News Tags: HIV/AIDS Commentary Source Type: news

Recent HIV/AIDS News
April 30, 2013: U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening for HIV “The U.S. Preventive Services Task Force (Task Force) today released its final recommendation statement on screening for HIV. The Task Force recommends that clinicians screen all people aged 15 to 65, as well as younger adolescents and older adults who are at an increased risk for HIV infection.” Read the AIDS.gov blog post. April 25, 2013: Prezista (Darunavir) Labeling Changes “On April 24, 2013, FDA approved revisions to the Prezista (darunavir) tablet and oral suspens...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - May 3, 2013 Category: Infectious Diseases Source Type: news

Treatment Of Panx1-Related Diseases Could Involve Food Dye
The food dye Brilliant Blue FCF (BB FCF) could be a useful tool in the development of treatments for a variety of conditions involving the membrane channel protein Pannexin 1(Panx1), according to a study in The Journal of General Physiology. Panx1, which is involved in signaling events leading to inflammation and cell death, has been implicated in such diverse diseases as Crohn's, AIDS, melanoma, epilepsy, spinal cord injury, and stroke, among others. Thus, there is a demand for the development of pharmacological tools to inhibit Panx1... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 1, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Quality control, analysis and secure sharing of Luminex(R) immunoassay data using the open source LabKey Server platform
Conclusions: Unlike other tools tailored for Luminex immunoassays, LabKey Server allows labs to customize their Luminex analyses using scripting while still presenting users with a single, graphical interface for processing and analyzing data. The LabKey Server system also stands out among Luminex tools for enabling smooth, secure transfer of data, quality control information, and analyses between collaborators. LabKey Server and its Luminex features are freely available as open source software at http://www.labkey.com under the Apache 2.0 license. (Source: BMC Bioinformatics - Latest articles)
Source: BMC Bioinformatics - Latest articles - April 30, 2013 Category: Bioinformatics Authors: Josh EckelsCory NatheElizabeth NelsonSara ShoemakerElizabeth NostrandNicole YatesVicki AshleyLinda HarrisMark BollenbeckYouyi FongGeorgia TomarasBritt Piehler Source Type: research

HIV Vaccine Study Halted Due to Failure to Prevent InfectionHIV Vaccine Study Halted Due to Failure to Prevent Infection
An interim analysis has revealed that an experimental vaccine failed to prevent HIV infection or reduce viral load among vaccine recipients who became infected with HIV. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2013 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

Uganda: HIV Vaccine Trial Ends in Failure
[New Vision]US authorities announced Thursday they have halted clinical trials of an experimental vaccine designed to halt the virus that leads to AIDS after discovering it did not stop infection. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - April 26, 2013 Category: Infectious Diseases Source Type: news

Latest HIV Vaccine Fails In The US, Government Stops Study
A study testing the latest experimental HIV vaccine has been stopped after an independent review board found that it did not prevent HIV infection and did not decrease the amount of HIV in the blood. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced that they will stop giving doses of this experimental vaccine. The trial, which began in 2009 is the most recent in a line of unsuccessful HIV vaccine studies... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 26, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

Working Group Consultation: Alloimmunity as a Vaccine Approach Against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012
AIDS Research and Human Retroviruses , Vol. 0, No. 0. (Source: AIDS Research and Human Retroviruses)
Source: AIDS Research and Human Retroviruses - April 25, 2013 Category: Infectious Diseases Tags: article Source Type: research

U.S.-Backed HIV Vaccine Fails; Study Halted
The National Institutes of Health on Thursday halted a study testing an experimental HIV vaccine after an independent review board found the vaccine did not prevent HIV infection and did not reduce the amount of HIV in the blood.Source: Reuters Health Related MedlinePlus Page: HIV/AIDS (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 25, 2013 Category: Consumer Health News Source Type: news

Transmitted founder HIV-1 biology [Microbiology]
Defining the virus–host interactions responsible for HIV-1 transmission, including the phenotypic requirements of viruses capable of establishing de novo infections, could be important for AIDS vaccine development. Previous analyses have failed to identify phenotypic properties other than chemokine receptor 5 (CCR5) and CD4+ T-cell tropism that are preferentially associated with... (Source: Proceedings of the National Academy of Sciences)
Source: Proceedings of the National Academy of Sciences - April 23, 2013 Category: Science Authors: Parrish, N. F., Gao, F., Li, H., Giorgi, E. E., Barbian, H. J., Parrish, E. H., Za&jnodot;ic, L., Iyer, S. S., Decker, J. M., Kumar, A., Hora, B., Berg, A., Cai, F., Hopper, J., Denny, T. N., Ding, H., Ochsenbauer, C., Kappes, J. C., Galimidi, R. P., West Tags: Inaugural Articles Biological Sciences Source Type: research

Recruitment of Urban US Women at Risk for HIV Infection and Willingness to Participate in Future HIV Vaccine Trials
(Source: AIDS and Behavior)
Source: AIDS and Behavior - April 22, 2013 Category: Infectious Diseases Authors: Metch, BarbaraFrank, IanNovak, RichardSwann, EdithMetzger, DavidMorgan, CeciliaLucy, DebbieDunbar, DeboraGraham, ParrieMadenwald, TamraEscamilia, GinaKoblin, Beryl Source Type: research

South Africa: Dept. of Health Withholding National Aids Vaccine Plan
[Health-e]Civil rights groups and communities have expressed their concerned about the failure of the Department of Health to release the National Aids Vaccine Strategic Plan (NAVSP) for 2013-2017. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 19, 2013 Category: African Health Source Type: news

HPV Vaccines May Not Be Effective in Women with HIV
A small but relevant study by the Fox Chase Cancer Center in Philadelphia suggests that women with HIV may not benefit from vaccines meant to prevent the development of certain cancer-causing forms of human papillomavirus (HPV)....Read Full Post (Source: About AIDS / HIV)
Source: About AIDS / HIV - April 17, 2013 Category: Consumer Health Advice Source Type: news

AIDS Healthcare Foundation gives hundreds of meningitis vaccines
AIDS Healthcare Foundation gives hundreds of free meningitis vaccinations after the death of West Hollywood lawyer who contracted the disease.Reacting to the death of a young West Hollywood lawyer over the weekend and growing concerns about the possible spread of bacterial meningitis, the AIDS Healthcare Foundation gave hundreds of free vaccinations to visitors who showed up Monday at its facilities. (Source: L.A. Times - Health)
Source: L.A. Times - Health - April 15, 2013 Category: Consumer Health News Source Type: news

HIV Vaccine Development May Be Guided By Antibody Evolution
Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body. The kind of antibody studied is called a broadly cross-reactive neutralizing antibody, and details of its generation could provide a blueprint for effective vaccination, according to the study's authors... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

Effective HIV Vaccine On The Horizon
By tracking the very earliest days of one person's robust immune response to HIV, researchers have charted a new route for developing a long-sought vaccine that could boost the body's ability to neutralize the virus. The research team, led by Barton F. Haynes, M.D., director of the Duke Human Vaccine Institute, and John Mascola, M.D., acting director of the NIH Vaccine Research Center, have for the first time described the co-evolution of antibodies and virus in a person with HIV whose immune system mounted a broad attack against the pathogen. Findings are published in the journal Nature... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 5, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

Researchers A Step Closer To Making HIV Vaccine
Researchers have charted a new route that could help develop a vaccine to boost a person's ability to neutralize the HIV virus, according to a recent study published in the journal Nature. Barton F. Haynes, M.D., director of the Duke Human Vaccine Institute, and John Mascola, M.D., acting director of the NIH Vaccine Research Center, led a team of researchers who studied an HIV infected person whose immune system attacked the pathogen, allowing them to describe the co-evolution of antibodies... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 5, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

NIH-Funded Scientists Map Possible Path to an HIV Vaccine
“In an advance for HIV vaccine research, scientists have for the first time determined how both the virus and a resulting strong antibody response co-evolved in one HIV-infected individual. The findings could help researchers identify which proteins to use in investigational vaccines to induce antibodies capable of preventing infection from an array of HIV strains. … “In the current study, scientists identified one of the roughly 20 percent of HIV-infected individuals who naturally develop broadly neutralizing antibodies to the virus after several years of infection. This person in Africa was a volunteer...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - April 5, 2013 Category: Infectious Diseases Source Type: news

Step toward AIDS vaccine?
Researchers report a breakthrough in generating powerful antibodies that can neutralize HIV. (Source: CNN.com - Health)
Source: CNN.com - Health - April 4, 2013 Category: Consumer Health News Source Type: news

Possible step toward AIDS vaccine development
Researchers report a breakthrough in generating powerful antibodies that can neutralize HIV. (Source: CNN.com - Health)
Source: CNN.com - Health - April 4, 2013 Category: Consumer Health News Source Type: news

New Online Tool Connects You With the Vaccines You Need
It's no secret that people living with HIV need their seasonal flu shots. But it's just as important for some to vaccinate themselves against such communicable diseases as hepatitis B or HPV (the latter of which has been linked to cervical and anal cancers in people with HIV). Surprisingly, convenience is cited as one of the reasons why people put off these shots, often for years at a time....Read Full Post (Source: About AIDS / HIV)
Source: About AIDS / HIV - April 4, 2013 Category: Consumer Health Advice Source Type: news

Antibody Points Researchers to a Possible HIV Vaccine Model
In a study published this week in the journal Nature, researchers at Duke University have reported the discovery of an antibody that may one day neutralize or diminish the infective potential of HIV....Read Full Post (Source: About AIDS / HIV)
Source: About AIDS / HIV - April 4, 2013 Category: Consumer Health Advice Source Type: news

Potential Blueprint for AIDS Vaccine
Researchers said Wednesday they have mapped an "arms race" in the human body between the AIDS virus and powerful antibodies that fight it off—the latest advance in the pursuit of a vaccine. (Source: WSJ.com: Health)
Source: WSJ.com: Health - April 3, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

AIDS Vaccine Path Suggested by Study
By tracking one patient’s immune response, scientists have discovered how a series of mutations led to an antibody that could defeat many H.I.V. strains. (Source: NYT Health)
Source: NYT Health - April 3, 2013 Category: Consumer Health News Authors: By DONALD G. McNEIL Jr. Tags: Viruses Acquired Immune Deficiency Syndrome Research Vaccination and Immunization Source Type: news

HIV: Roadmaps to a vaccine
Nature advance online publication 03 April 2013. doi:10.1038/nature12091 Authors: Hugo Mouquet & Michel C. Nussenzweig More than 30 years since the AIDS pandemic began, there is still no effective vaccine. But analysis of broadly acting, potent human antibodies obtained from single cells suggests a rational approach to vaccine development. (Source: Nature AOP)
Source: Nature AOP - April 3, 2013 Category: Research Authors: Hugo MouquetMichel C. Nussenzweig Tags: News & Views Source Type: research

HIV: Roadmaps to a vaccine
nzweig More than 30 years since the AIDS pandemic began, there is still no effective vaccine. But analysis of broadly acting, potent human antibodies obtained from single cells suggests a rational approach to vaccine development. See Article p.469 (Source: Nature)
Source: Nature - April 3, 2013 Category: Research Authors: Hugo MouquetMichel C. Nussenzweig Tags: News & Views Source Type: research

Designer Antibodies For HIV
An effective vaccine against HIV-1 remains elusive, but one promising strategy focuses on designer antibodies that have much broader potency than most normal, exquisitely specific antibodies. These broadly neutralizing antibodies (bNAbs) can handle the high mutation rate of HIV particles that makes normal, very specific antibodies useless within a short space of time. A study published by Cell Press in the journal Cell reveals surprising mutations in these antibodies that are crucial for strong protection against HIV-1. The findings could guide efforts to design better HIV-1 vaccines... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 2, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

Bayesian semiparametric mixture Tobit models with left censoring, skewness, and covariate measurement errors
Common problems to many longitudinal HIV/AIDS, cancer, vaccine, and environmental exposure studies are the presence of a lower limit of quantification of an outcome with skewness and time‐varying covariates with measurement errors. There has been relatively little work published simultaneously dealing with these features of longitudinal data. In particular, left‐censored data falling below a limit of detection may sometimes have a proportion larger than expected under a usually assumed log‐normal distribution. In such cases, alternative models, which can account for a high proportion of censored data, should be consi...
Source: Statistics in Medicine - April 2, 2013 Category: Statistics Authors: Getachew A. Dagne, Yangxin Huang Tags: Research Article Source Type: research

HIV And Other Fast-Mutating Viruses Targeted By New Vaccine-Design Approach
A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses. The report, which appears in Science Express, the early online edition of the journal Science, offers a step toward solving what has been one of the central problems of modern vaccine design: how to stimulate the immune system to produce the right kind of antibody response to protect against a wide range of viral strains... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 1, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

New vaccine-design approach targets HIV and other fast-mutating viruses
(Scripps Research Institute) A team led by scientists from The Scripps Research Institute and the International AIDS Vaccine Initiative has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 28, 2013 Category: Global & Universal Source Type: news

Method To Identify Weak Points In Viral Proteins That Could Be Exploited For HIV Vaccine Development
Decades of research and three large-scale clinical trials have so far failed to yield an effective HIV vaccine, in large part because the virus evolves so rapidly that it can evade any vaccine-induced immune response. Researchers from the Ragon Institute of MGH, MIT and Harvard University have now developed a new approach to vaccine design that may allow them to cut off those evolutionary escape routes... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 26, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

An Effective HIV Vaccine May Be Possible By Harnessing Immune Cells' Adaptability To Design
In infected individuals, HIV mutates rapidly to escape recognition by immune cells. This process of continuous evolution is the main obstacle to natural immunity and the development of an effective vaccine. A new study published by Cell Press in the journal Immunity reveals that the immune system has the capacity to adapt such that it can recognize mutations in HIV. The findings suggest that our immune cells' adaptability could be harnessed to help in the fight against AIDS... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 25, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

A Step Closer To Explaining How Long-Term Infections Occur: Immune Finding Aids Quest For Vaccines To Beat Tropical Infections
Scientists are a step closer to developing vaccines for a range of diseases that affect 200 million people, mainly in tropical south-east Asia, Africa and Central America. Researchers studying infections caused by parasitic worms - which can lead to diseases such as elephantiasis and river blindness - have shown how these can shut down a part of the immune system that might otherwise fight sickness. Preventing this immune reaction enables the infection to persist, causing chronic illness... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 18, 2013 Category: Consumer Health News Tags: Tropical Diseases Source Type: news

Researchers Advance Fight Against Leading Infectious Cause Of Congenital Birth Defects
La Jolla Institute and Cardiff University Discovery Aids Efforts Toward Cytomegalovirus Vaccine A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today. Because of cytomegalovirus (CMV) infection during in utero development, 1 in 750 children are born with or develop permanent disabilities such as hearing loss or brain damage. But efforts to develop a first-ever CMV vaccine are gaining ground... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 15, 2013 Category: Consumer Health News Tags: Pediatrics / Children's Health Source Type: news

HIV Vaccine Development: Strategies for Preclinical and Clinical Investigation
AIDS Research and Human Retroviruses , Vol. 0, No. 0. (Source: AIDS Research and Human Retroviruses)
Source: AIDS Research and Human Retroviruses - March 8, 2013 Category: Infectious Diseases Tags: article Source Type: research

The 30-year fight against HIV
Since its identification as the cause of Aids in 1984, scientists have made major advancements in tackling virus1984 Retrovirus is discovered as cause of Aids and later named human immunodeficiency virus or HIV.1986 Clinical trials show that HIV patients taking AZT (azidothymidine), an antiretroviral drug initially developed as a cancer therapy, were living longer than those who did not. AZT is shown to manage, but not cure, HIV and reduce the rates of mother-to-child infection in pregnancy.1987 The US FDA approves AZT as the first antiretroviral to be used as a treatment for Aids.1995 Jeff Getty, Aids activist, becomes th...
Source: Guardian Unlimited Science - March 3, 2013 Category: Science Authors: Caroline Davies Tags: The Guardian News Health Medical research Aids and HIV Society Source Type: news

Cultural Values Influencing Immigrant Haitian Mothers' Attitudes Toward Human Papillomavirus Vaccination for Daughters
This study identifies cultural beliefs influencing 31 immigrant Haitian mothers’ willingness to vaccinate their daughters against HPV using semistructured interviews. Mothers had low levels of HPV and HPV vaccine knowledge, and desired more information. Concerns centered on cultural values regarding adolescent sexuality and HIV/AIDS stigmas specific to Haitian communities. If vaccination were recommended by a physician, mothers are more likely to have their daughters vaccinated. HPV vaccination uptake efforts targeting Haitian months should emphasize physician involvement and incorporate culturally relevant health co...
Source: Journal of Black Psychology - March 1, 2013 Category: Psychiatry & Psychology Authors: Stephens, D. P., Thomas, T. L. Tags: Articles Source Type: research

Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.
Abstract Globally, tuberculosis (TB) still remains a major public health problem. India is a high TB burden country contributing to 26 per cent of global TB burden. During 1944-1980, TB became treatable and short-course chemotherapy emerged as the standard of care. When TB elimination seemed possible in the early 1980s, global human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS) pandemic resulted in a resurgence of TB. Widespread occurrence of multidrug-resistant and extensively drug-resistant TB (M/XDR-TB) is threatening to destabilize TB control globally. Atypical clinical presen...
Source: The Indian Journal of Medical Research - March 1, 2013 Category: Biomedical Science Authors: Sharma SK, Mohan A Tags: Indian J Med Res Source Type: research

Development Of Life-Saving Tools Against Major Killers Could Be Jeopardized By US Budget Cuts
Across-the-board cuts to US R&D programs could have a devastating impact on efforts to develop new drugs for tuberculosis (TB) and HIV/AIDS, the world's first malaria vaccine, and other vital global health products in development, according to a new report from a coalition of nonprofit groups focused on advancing innovation to save lives. "We know that policymakers are currently facing difficult budget decisions... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 28, 2013 Category: Consumer Health News Tags: Public Health Source Type: news

U.S. Cuts to Global Health Budget “Mass-scale Malpractice”
Public health workers, activists and policymakers are stepping up a last-minute campaign to highlight the global health impact of historic, sweeping cuts to the U.S. federal budget due to go into effect Friday if Congress doesn’t act. While some are suggesting that the automatic reductions, known here as the “sequester”, could set back health-related research and outcomes by a generation, others are warning that NGOs and project implementers, long working on the assumption that the cutbacks would be averted, are now finding themselves massively underprepared for how to operate on slashed budgets. “While these budge...
Source: IPS Inter Press Service - Health - February 26, 2013 Category: Global & Universal Authors: Carey L. Biron Tags: Active Citizens Aid Development & Aid Financial Crisis Headlines Health North America Poverty & MDGs Women's Health World HIV/AIDS sequester United States Source Type: news

Africa: Report Warns U.S. Budget Cuts Could Jeopardize Aids, TB and Malaria Work
[Global Health Technologies Coalition]Washington, DC (26 February 2013) -Across-the-board cuts to US R&D programs could have a devastating impact on efforts to develop new drugs for tuberculosis (TB) and HIV/AIDS, the world's first malaria vaccine, and other vital global health products in development, according to a new report from a coalition of nonprofit groups focused on advancing innovation to save lives. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 26, 2013 Category: African Health Source Type: news